OS Therapies OSTX Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants at other companies
Other financials
Where this comes from
Reported directly by OS Therapies in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants.
The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about OS Therapies's proceeds from issuance of preferred stock preference stock and warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OS Therapies's proceeds from issuance of preferred stock preference stock and warrants?
- OS Therapies (OSTX) reported proceeds from issuance of preferred stock preference stock and warrants of $1.05M in Q1 2025.
- How has OS Therapies's proceeds from issuance of preferred stock preference stock and warrants changed year-over-year?
- OS Therapies's proceeds from issuance of preferred stock preference stock and warrants decreased by 30.4% year-over-year, from $1.51M to $1.05M.
- What does proceeds from issuance of preferred stock preference stock and warrants mean?
- Represents the total cash inflows received from the sale of preferred equity securities and associated warrants to investors. This metric highlights the company's ability to raise capital through hybrid equity instruments that often carry specific dividend or liquidation preferences.